Glubitor: Each tablet contains 80 mg gliclazide.
Glubitor-OD: MR tab: Each modified-release tablet contains: Gliclazide 30 mg.
Gliclazide (Glubitor-OD) 30 mg is a modified-release, white, plain, elliptical tablet intended for once-daily dosing to improve patient compliance and glycemic control in patients with type 2 diabetes.
PR tab: Each prolonged-release tablet contains: Gliclazide 60 mg.
Other Services
Country
Account